Clinical Trial Update: Safety Study of Pioglitazone Compared To Glyburide on Liver Function [Phase 4]

View source ↗

Summary

Phase 4 safety study comparing pioglitazone to glyburide examined effects on liver function in patients with diabetes mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Glyburide (glyburide)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Liver | Phase 4 | Status: COMPLETED